Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL31P43 (Ribosomal protein L31 pseudogene 43) is a processed pseudogene derived from the ribosomal protein L31 gene. Pseudogenes are segments of DNA similar to normal genes but typically non-functional due to mutations that prevent them from coding for proteins. RPL31P43 has sequence homology to the functional *RPL31* gene, which encodes a component of the 60S ribosomal subunit and is essential for protein synthesis in cells. Unlike the active ribosomal protein L31, RPL31P43 is not transcribed into a functional protein and does not serve known biological or therapeutic roles. It may exist as an expressed non-coding RNA, but no studies have characterized specific regulatory or disease-related functions of RPL31P43. It is catalogued among many processed pseudogenes in the human genome, particularly for ribosomal proteins, but is not a validated drug target, biomarker, or therapeutic receptor. If you are seeking information on the functional ribosomal protein, refer to *RPL31* instead of its pseudogene variants.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 43 (RPL31P43).